217 related articles for article (PubMed ID: 31302813)
1. Disability in multiple sclerosis is associated with age and inflammatory, metabolic and oxidative/nitrosative stress biomarkers: results of multivariate and machine learning procedures.
Flauzino T; Simão ANC; de Carvalho Jennings Pereira WL; Alfieri DF; Oliveira SR; Kallaur AP; Lozovoy MAB; Kaimen-Maciel DR; Maes M; Reiche EMV
Metab Brain Dis; 2019 Oct; 34(5):1401-1413. PubMed ID: 31302813
[TBL] [Abstract][Full Text] [Related]
2. Genetic, Immune-Inflammatory, and Oxidative Stress Biomarkers as Predictors for Disability and Disease Progression in Multiple Sclerosis.
Kallaur AP; Reiche EMV; Oliveira SR; Simão ANC; Pereira WLCJ; Alfieri DF; Flauzino T; Proença CM; Lozovoy MAB; Kaimen-Maciel DR; Maes M
Mol Neurobiol; 2017 Jan; 54(1):31-44. PubMed ID: 26732588
[TBL] [Abstract][Full Text] [Related]
3. Immune-Inflammatory and Oxidative and Nitrosative Stress Biomarkers of Depression Symptoms in Subjects with Multiple Sclerosis: Increased Peripheral Inflammation but Less Acute Neuroinflammation.
Kallaur AP; Lopes J; Oliveira SR; Simão AN; Reiche EM; de Almeida ER; Morimoto HK; de Pereira WL; Alfieri DF; Borelli SD; Kaimen-Maciel DR; Maes M
Mol Neurobiol; 2016 Oct; 53(8):5191-202. PubMed ID: 26399644
[TBL] [Abstract][Full Text] [Related]
4. Immune-Inflammatory, Metabolic, Oxidative, and Nitrosative Stress Biomarkers Predict Acute Ischemic Stroke and Short-Term Outcome.
Alfieri DF; Lehmann MF; Flauzino T; de Araújo MCM; Pivoto N; Tirolla RM; Simão ANC; Maes M; Reiche EMV
Neurotox Res; 2020 Aug; 38(2):330-343. PubMed ID: 32415527
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D deficiency is associated with disability and disease progression in multiple sclerosis patients independently of oxidative and nitrosative stress.
Oliveira SR; Simão ANC; Alfieri DF; Flauzino T; Kallaur AP; Mezzaroba L; Lozovoy MAB; Sabino BS; Ferreira KPZ; Pereira WLCJ; Kaimen-Maciel DR; Dichi I; Reiche EMV
J Neurol Sci; 2017 Oct; 381():213-219. PubMed ID: 28991684
[TBL] [Abstract][Full Text] [Related]
6. Immune-inflammatory, metabolic and hormonal biomarkers are associated with the clinical forms and disability progression in patients with multiple sclerosis: A follow-up study.
de Carvalho Jennings Pereira WL; Flauzino T; Alfieri DF; Oliveira SR; Kallaur AP; Simão ANC; Lozovoy MAB; Kaimen-Maciel DR; Maes M; Reiche EMV
J Neurol Sci; 2020 Mar; 410():116630. PubMed ID: 31887671
[TBL] [Abstract][Full Text] [Related]
7. Insulin resistance, atherogenicity, and iron metabolism in multiple sclerosis with and without depression: Associations with inflammatory and oxidative stress biomarkers and uric acid.
Oliveira SR; Kallaur AP; Lopes J; Colado Simão AN; Reiche EM; de Almeida ERD; Morimoto HK; de Carvalho Jennings de Pereira WL; Alfieri DF; Flauzino T; de Meleck Proença C; Gomes AM; Kaimen-Maciel DR; Maes M
Psychiatry Res; 2017 Apr; 250():113-120. PubMed ID: 28152396
[TBL] [Abstract][Full Text] [Related]
8. Antioxidant and Anti-inflammatory Diagnostic Biomarkers in Multiple Sclerosis: A Machine Learning Study.
Mezzaroba L; Simão ANC; Oliveira SR; Flauzino T; Alfieri DF; de Carvalho Jennings Pereira WL; Kallaur AP; Lozovoy MAB; Kaimen-Maciel DR; Maes M; Reiche EMV
Mol Neurobiol; 2020 May; 57(5):2167-2178. PubMed ID: 31970657
[TBL] [Abstract][Full Text] [Related]
9. Oxidative stress in multiple sclerosis patients in clinical remission: association with the expanded disability status scale.
Oliveira SR; Kallaur AP; Simão AN; Morimoto HK; Lopes J; Panis C; Petenucci DL; da Silva E; Cecchini R; Kaimen-Maciel DR; Reiche EM
J Neurol Sci; 2012 Oct; 321(1-2):49-53. PubMed ID: 22883481
[TBL] [Abstract][Full Text] [Related]
10. Elevated plasma homocysteine levels are associated with disability progression in patients with multiple sclerosis.
Oliveira SR; Flauzino T; Sabino BS; Kallaur AP; Alfieri DF; Kaimen-Maciel DR; Morimoto HK; de Almeida ERD; Lozovoy MAB; Reiche EMV; Dichi I; Simão ANC
Metab Brain Dis; 2018 Oct; 33(5):1393-1399. PubMed ID: 29797117
[TBL] [Abstract][Full Text] [Related]
11. High-density lipoprotein cholesterol is associated with multiple sclerosis fatigue: A fatigue-metabolism nexus?
Browne RW; Jakimovski D; Ziliotto N; Kuhle J; Bernardi F; Weinstock-Guttman B; Zivadinov R; Ramanathan M
J Clin Lipidol; 2019; 13(4):654-663.e1. PubMed ID: 31307953
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D and body mass index in Egyptian multiple sclerosis patients.
Zamzam D; Foad M; Swelam M; AbdelHafez M; AbdelNasser A; Mahmoud R; Aref H; Zakaria M
Mult Scler Relat Disord; 2019 Feb; 28():313-316. PubMed ID: 30823981
[TBL] [Abstract][Full Text] [Related]
13. Disability in patients with multiple sclerosis: influence of insulin resistance, adiposity, and oxidative stress.
Oliveira SR; Simão AN; Kallaur AP; de Almeida ER; Morimoto HK; Lopes J; Dichi I; Kaimen-Maciel DR; Reiche EM
Nutrition; 2014 Mar; 30(3):268-73. PubMed ID: 24484677
[TBL] [Abstract][Full Text] [Related]
14. An adverse lipid profile is associated with disability and progression in disability, in people with MS.
Tettey P; Simpson S; Taylor B; Blizzard L; Ponsonby AL; Dwyer T; Kostner K; van der Mei I
Mult Scler; 2014 Nov; 20(13):1737-44. PubMed ID: 24829292
[TBL] [Abstract][Full Text] [Related]
15. Disease progression and oxidative stress are associated with higher serum ferritin levels in patients with multiple sclerosis.
Ferreira KPZ; Oliveira SR; Kallaur AP; Kaimen-Maciel DR; Lozovoy MAB; de Almeida ERD; Morimoto HK; Mezzaroba L; Dichi I; Reiche EMV; Simão ANC
J Neurol Sci; 2017 Feb; 373():236-241. PubMed ID: 28131195
[TBL] [Abstract][Full Text] [Related]
16. Inter-dependence of vitamin D levels with serum lipid profiles in multiple sclerosis.
Weinstock-Guttman B; Zivadinov R; Ramanathan M
J Neurol Sci; 2011 Dec; 311(1-2):86-91. PubMed ID: 21849177
[TBL] [Abstract][Full Text] [Related]
17. [Relationship between serum homocysteine and metabolic syndrome: a cross-sectional study].
Feng SQ; Ye P; Luo LM; Xiao WK; Xu RY; Wu HM
Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Mar; 33(3):256-9. PubMed ID: 22613373
[TBL] [Abstract][Full Text] [Related]
18. Factors influencing insulin resistance in relation to atherogenicity in mood disorders, the metabolic syndrome and tobacco use disorder.
Bortolasci CC; Vargas HO; Vargas Nunes SO; de Melo LG; de Castro MR; Moreira EG; Dodd S; Barbosa DS; Berk M; Maes M
J Affect Disord; 2015 Jul; 179():148-55. PubMed ID: 25863911
[TBL] [Abstract][Full Text] [Related]
19. Is there an association between the Expanded Disability Status Scale and inflammatory markers in multiple sclerosis?
Guzel I; Mungan S; Oztekin ZN; Ak F
J Chin Med Assoc; 2016 Feb; 79(2):54-7. PubMed ID: 26589195
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of overweight, obesity and metabolic syndrome components in multiple sclerosis patients with significant disability.
Pinhas-Hamiel O; Livne M; Harari G; Achiron A
Eur J Neurol; 2015 Sep; 22(9):1275-9. PubMed ID: 25973530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
